NCT05074238

Brief Summary

The purpose of this study is to determine the potential influence of sun protection on the aesthetic outcome of post-surgical scars following the reconstruction of Mohs micrographic surgery defects via linear repair. This study will be performed as a randomized split-wound study. Half of the wound will be treated with zinc containing sunscreen and the other half of the wound would not be treated. Three-months post-surgery, the scar will be evaluated via the patient observer scar assessment scale (POSAS), a validated scar instrument, as well as a colorimeter to measure the amount of vascularity, and hyperpigmentation between the treated and the non-treated area compared to the 'surrounding skin' defined as skin in the proximity but not adjacent to the wound. Any adverse events will also be recorded.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Jul 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jul 2021Aug 2026

Study Start

First participant enrolled

July 16, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 29, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 12, 2021

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

3.4 years

First QC Date

September 29, 2021

Last Update Submit

March 26, 2026

Conditions

Keywords

Sun ProtectionCutaneous SurgeryWound Closure

Outcome Measures

Primary Outcomes (1)

  • Patient observer assessment score (POSAS)

    The primary end point will be the two blinded reviewers sum of the component parts of the patient observer assessment score (POSAS). The observer scale of the POSAS consists of six items (vascularity, pigmentation, thickness, relief, pliability and surface area). All items are scored on a scale ranging from 1 ('like normal skin') to 10 ('worst scar imaginable'). The sum of the six items results in a total score of the POSAS observer scale. Categories boxes are added for each item. Furthermore, an overall opinion is scored on a scale ranging from 1 to 10.

    3-12 months

Secondary Outcomes (1)

  • Colorimeter measurement of wound vascularity and hyperpigmentation.

    3-12 months

Study Arms (2)

Sunscreen Application

EXPERIMENTAL

The study participant will be instructed to start applying the sunscreen provided to them to the randomly assigned half of the wound (A or B).

Other: Zinc containing suncreen

No Suncreen Application

EXPERIMENTAL

The study participant will be instructed to not apply the sunscreen provided to them to the randomly assigned half of the wound (A or B).

Other: Zinc containing suncreen

Interventions

The study participant will be randomized via a randomization tool within the REDCap database as to which half of the wound ("A" or "B") the patient will be asked to apply zinc containing sunscreen for the duration of the study.

No Suncreen ApplicationSunscreen Application

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is ≥ 18 years of age
  • Patient is able to provide informed consent
  • Patient is scheduled for a cutaneous excisional surgical procedure
  • Cutaneous surgical wound closed via linear repair
  • Surgery performed on sunlight-exposed anatomical regions (head, face, neck, hairless scalp)
  • Patient is willing to return for follow-up visit to clinic

You may not qualify if:

  • Patient is incarcerated
  • Patient is \< 18 years of age
  • Patient is pregnant
  • Patient unwilling to return for 3-month follow-up
  • History of reaction to zinc containing sunscreen
  • History of collagen vascular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Davis

Sacramento, California, 95816, United States

Location

MeSH Terms

Conditions

Surgical WoundCicatrix

Condition Hierarchy (Ancestors)

Wounds and InjuriesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Factorial Assignment At the follow-up visit, two blinded observers will record their scores independently using the physician observer scar assessment score instrument (POSAS).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2021

First Posted

October 12, 2021

Study Start

July 16, 2021

Primary Completion

December 1, 2024

Study Completion (Estimated)

August 1, 2026

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations